Observational Data Show 55% Combined CKD, HF or Death Risk at 10 Years Post-T2D Diagnosis
Large US observational cohort links type 2 diabetes diagnosis to sharply rising cardiorenal mortality risk over a decade. Early multimorbidity clustering and bidirectional progression between CKD and HF dominate the trajectory. Integrated screening and therapy intensification remain untested in this dataset.
Researchers used the CALOR real-world program to track patients diagnosed 2010-2024. CKD occurred first in 19% within five years versus 8.3% for heart failure; once heart failure appeared first, subsequent five-year CKD risk hit 42%. The study population averaged age 59, 51% female, with high rates of hypertension and dyslipidemia. Because the design is observational, it cannot separate causation from confounding by unmeasured factors such as glycemic control or medication adherence.
Sattar et al.: Integrated SGLT2/GLP-1 prescribing rates above 40% in newly diagnosed T2D cohorts will lower 10-year combined CKD/HF/death incidence by at least 8 percentage points by 2032.
Sources (3)
- [1]Primary Source(https://www.easd.org/annual-meeting/2026)
- [2]Supporting Source(https://www.thelancet.com/journals/landia/article/PIIS2213-8587(23)00123-4/fulltext)
- [3]Supporting Source(https://jamanetwork.com/journals/jama/fullarticle/2801234)